ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1
| Status: | Completed |
|---|---|
| Conditions: | Atrial Fibrillation |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/5/2017 |
| Start Date: | October 2015 |
| End Date: | March 2, 2017 |
The goal of this study is to learn about the patient and provider perceptions, priorities,
preferences, and willingness to use/prescribe anticoagulation as a stroke prevention therapy
in patients with atrial fibrillation. Qualitative interviews will be performed with atrial
fibrillation patients and providers caring for atrial fibrillation patients. The
investigators want to understand the factors that influence decision-making about
anticoagulation medications, and to gain insight into patients' and providers' knowledge of
the risk of stroke and bleeding associated with oral anticoagulation. This feedback will
help provide better education to providers caring for patients with atrial fibrillation and
better care to patients with atrial fibrillation by developing tools to optimize the
appropriate use of oral anticoagulation for patients with atrial fibrillation.
preferences, and willingness to use/prescribe anticoagulation as a stroke prevention therapy
in patients with atrial fibrillation. Qualitative interviews will be performed with atrial
fibrillation patients and providers caring for atrial fibrillation patients. The
investigators want to understand the factors that influence decision-making about
anticoagulation medications, and to gain insight into patients' and providers' knowledge of
the risk of stroke and bleeding associated with oral anticoagulation. This feedback will
help provide better education to providers caring for patients with atrial fibrillation and
better care to patients with atrial fibrillation by developing tools to optimize the
appropriate use of oral anticoagulation for patients with atrial fibrillation.
Patient Inclusion Criteria:
1. adult patient age 18 or older;
2. English speaking;
3. diagnosed atrial fibrillation;
4. at least 1 risk factor for congestive heart failure, hypertension, age, diabetes,
stroke (CHADS2) or 2 risk factors for CHADS2 with vascular disease, age, and sex
(CHADS2-VASc) ;
5. no documented cognitive impairment per the medical record;
6. not being prescribed an oral anticoagulant
Provider Inclusion Criteria:
1. physician at one of the study sites treating patients diagnosed with atrial
fibrillation
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials
